Gene: MRPL58
Official Full Name: mitochondrial ribosomal protein L58provided by HGNC
Gene Summary: The protein encoded by this gene is a peptidyl-tRNA hydrolase and a vital component of the large mitochondrial ribosome. The encoded protein serves as a ribosome release factor for this ribosome, which translates mitochondrial genes. This protein may be responsible for degrading prematurely-terminated polypeptides and for reusing stalled ribosomes. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO37139 | MRPL58 Knockout cell line (HeLa) | Human | MRPL58 | 1:3~1:6 | Negative | Online Inquiry |
KO37140 | MRPL58 Knockout cell line (HCT 116) | Human | MRPL58 | 1:2~1:4 | Negative | Online Inquiry |
KO37141 | MRPL58 Knockout cell line (HEK293) | Human | MRPL58 | 1:3~1:6 | Negative | Online Inquiry |
KO37142 | MRPL58 Knockout cell line (A549) | Human | MRPL58 | 1:3~1:4 | Negative | Online Inquiry |
MRPL58 Gene Knockout Cell Lines are specialized cellular models engineered to contain a targeted disruption of the MRPL58 gene, which encodes a mitochondrial ribosomal protein integral to mitochondrial function and protein synthesis. This specific knockout allows for comprehensive analyses of mitochondrial dynamics, gene expression, and metabolic pathways, providing crucial insights into various biological processes and diseases linked to mitochondrial dysfunction.
These cell lines operate through a precise mechanism of gene editing, enriched by CRISPR-Cas9 technology that ensures high specificity and efficiency in gene disruption. Researchers can use MRPL58 knockout cells to examine the roles of mitochondrial protein synthesis in cancer metabolism, neurodegenerative diseases, and various genetic disorders. The resultant phenotypic changes, as evidenced by metabolic profiling and mitochondrial respiration assays, reveal the consequences of impaired mitochondrial function, making these cell lines invaluable for understanding disease mechanics.
The scientific importance of MRPL58 Gene Knockout Cell Lines lies in their application as a tool for therapeutic target validation and drug discovery. They allow researchers to investigate the effects of potential pharmacological agents on mitochondrial function in conditions where MRPL58 is implicated. Unique advantages include their robustness for in vitro experiments, compatibility with high-throughput screening, and contribution to a more refined understanding of mitochondrial diseases.
For researchers and clinicians, the MRPL58 Gene Knockout Cell Lines represent a significant advancement over traditional models, enabling deeper exploration of mitochondrial biology and its implications for human health. The precise knockout facilitates reproducible results that can directly inform the development of new therapies.
Our company specializes in providing cutting-edge biological products backed by extensive expertise in molecular biology and genetic engineering. With a commitment to quality and innovation, we offer researchers the tools they need to push the boundaries of scientific understanding and advance medical research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.